[PHARMA] YoY Annualized Quarter Result on 31-Mar-2009 [#1]

Announcement Date
08-May-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Mar-2009 [#1]
Profit Trend
QoQ- -3.24%
YoY- -21.69%
Quarter Report
View:
Show?
Annualized Quarter Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 1,786,980 1,541,312 1,270,240 1,254,864 1,238,600 1,024,940 1,003,016 10.09%
PBT 171,820 87,168 49,724 80,736 109,496 40,920 35,644 29.94%
Tax -55,576 -24,772 -12,488 -21,964 -33,568 -14,948 -11,980 29.11%
NP 116,244 62,396 37,236 58,772 75,928 25,972 23,664 30.34%
-
NP to SH 114,740 61,936 37,228 58,088 74,180 24,276 21,836 31.81%
-
Tax Rate 32.35% 28.42% 25.11% 27.20% 30.66% 36.53% 33.61% -
Total Cost 1,670,736 1,478,916 1,233,004 1,196,092 1,162,672 998,968 979,352 9.30%
-
Net Worth 474,161 437,661 439,675 402,378 367,905 321,111 335,032 5.95%
Dividend
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Div 35,297 - - - - - - -
Div Payout % 30.76% - - - - - - -
Equity
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Net Worth 474,161 437,661 439,675 402,378 367,905 321,111 335,032 5.95%
NOSH 117,657 107,007 106,977 107,015 106,949 107,037 107,039 1.58%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin 6.51% 4.05% 2.93% 4.68% 6.13% 2.53% 2.36% -
ROE 24.20% 14.15% 8.47% 14.44% 20.16% 7.56% 6.52% -
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 1,518.79 1,440.38 1,187.40 1,172.60 1,158.12 957.56 937.05 8.37%
EPS 97.52 57.88 34.80 54.28 69.36 22.68 20.40 29.75%
DPS 30.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 4.03 4.09 4.11 3.76 3.44 3.00 3.13 4.29%
Adjusted Per Share Value based on latest NOSH - 107,015
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 123.99 106.94 88.14 87.07 85.94 71.12 69.59 10.09%
EPS 7.96 4.30 2.58 4.03 5.15 1.68 1.52 31.74%
DPS 2.45 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 0.329 0.3037 0.3051 0.2792 0.2553 0.2228 0.2325 5.95%
Price Multiplier on Financial Quarter End Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 -
Price 5.90 5.73 4.27 3.45 2.95 3.55 4.73 -
P/RPS 0.39 0.40 0.36 0.29 0.25 0.37 0.50 -4.05%
P/EPS 6.05 9.90 12.27 6.36 4.25 15.65 23.19 -20.04%
EY 16.53 10.10 8.15 15.73 23.51 6.39 4.31 25.08%
DY 5.08 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.46 1.40 1.04 0.92 0.86 1.18 1.51 -0.55%
Price Multiplier on Announcement Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 03/05/12 13/05/11 26/05/10 08/05/09 28/05/08 25/05/07 25/05/06 -
Price 5.90 5.05 4.71 3.82 3.45 3.45 4.53 -
P/RPS 0.39 0.35 0.40 0.33 0.30 0.36 0.48 -3.39%
P/EPS 6.05 8.72 13.53 7.04 4.97 15.21 22.21 -19.47%
EY 16.53 11.46 7.39 14.21 20.10 6.57 4.50 24.19%
DY 5.08 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.46 1.23 1.15 1.02 1.00 1.15 1.45 0.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment